CTI Announces Dr. Varvara Grichko, Ph.D. was Appointed to the Board of Directors

LOS ANGELES, Sept. 21 /PRNewswire-FirstCall/ -- Cavitation Technologies, Inc. (CTI) (OTC Bulletin Board: CVAT & Berlin/Stuttgart: WTC) is very pleased and proud to announce that on September 8, 2010, Dr. VARVARA GRICHKO, Ph.D. was appointed to our Board of Directors. Dr. Grichko is a highly decorated chemist and biologist. She received her B.S./M.S. in biochemistry/chemistry at the Novosibirsk State University in Russia. Dr. Grichko holds a Ph.D. in Chemistry from the Russian Academy of Science and a Ph.D in biology from the University of Waterloo in Canada. Before joining CTI in 2008, Dr. Grichko was a research scientist and adjunct Professor at the Departments of Molecular and Structural Biochemistry and Materials Science and Engineering at North Carolina State University in Raleigh, NC. She was also a co-founder and Director of Assay Development at Nanolytics, Inc. in Raleigh, NC.  In her earlier career, Dr. Grichko was a Director of Microbiochemical Lab, at the Marquette University in Milwaukee, WI. Dr. Grichko has contributed to several books and papers in Chemistry and Biology and holds an impressive list of patents with the US, European and Russian Patent offices.

CTI's CEO Roman Gordon commented, "We are excited and pleased to have Dr. Grichko joining our Board.  We look forward to her future contributions in R&D to further expand the applications of our recently commercialized technology into other industries."

About Cavitation Technologies

Cavitation Technologies, Inc. (CTI); (OTCBB: CVAT); is a "Green-Tech" company, established in 2006 to become a world leader in the development of new cutting edge technologies for the vegetable oil refining, renewable fuel, petroleum, water treatment, wastewater sanitation, food and beverage, and chemical industries. For additional information please visit: www.cavitationtechnologies.com

Safe Harbor: Pursuant to the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995, and within the meaning of Section 27A of the Securities Act of 1933 and Section 21B of the Exchange Act of 1934, any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals and assumptions of future events or performance are not statements of historical fact and may be "forward-looking statements." Forward-looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward-looking statements in this release may be identified through the use of words such as "expects," "will," "anticipates," "estimates," "believes," or statements indicating certain actions such as "may," "could," or "might" occur. Such statements reflect the current views of CTI with respect to future events and are subject to certain assumptions, including those described in this release. These forward-looking statements involve a number of risks and uncertainties, including the timely development and market acceptance of products, services, and technologies, competitive market conditions, successful integration of acquisitions, the ability to secure additional sources of financing, the ability to reduce operating expenses and other factors. The actual results that the Company achieves may differ materially from any forward-looking statements due to such risks and uncertainties. Cavitation Technologies, Inc. does not undertake any responsibility to update the "forward-looking" statements contained in this news release.

SOURCE Cavitation Technologies, Inc.

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED